Information Provided By: 
Fly News Breaks for January 3, 2017
BCR
Jan 3, 2017 | 08:19 EDT
As previously reported, Morgan Stanley upgraded C.R. Bard to Overweight from Equal Weight with a new $260 price target. Analyst David Lewis expects is positive on Bard's diversified and insulated growth and said the company is never reliant on any one product or division and expects new product cadence to continue in 2017. Lewis sees share gains in Surgical, Oncology, and broader emerging market growth as drivers and expects the earnings inflection that started in Q1 2016 to continue in 2017.
News For BCR From the Last 2 Days
There are no results for your query BCR
